[HTML][HTML] Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions

P Lu, D Ruan, M Huang, M Tian, K Zhu… - … and Targeted Therapy, 2024 - nature.com
The applications of hydrogels have expanded significantly due to their versatile, highly
tunable properties and breakthroughs in biomaterial technologies. In this review, we cover …

Factors contributing to the rising national cost of glucose-lowering medicines for diabetes during 2005–2007 and 2015–2017

X Zhou, SS Shrestha, H Shao, P Zhang - Diabetes Care, 2020 - Am Diabetes Assoc
OBJECTIVE We examined changes in glucose-lowering medication spending and
quantified the magnitude of factors that are contributing to these changes. RESEARCH …

Customizable drug tablets with constant release profiles via 3D printing technology

YJN Tan, WP Yong, HR Low, JS Kochhar… - International journal of …, 2021 - Elsevier
Medicine should ideally be personalized as each individual has his/her own unique
biological, physical, and medical dispositions. Medicine can be personalized by customizing …

[HTML][HTML] Spending by the Centers for Medicare & Medicaid Services before and after confirmation of benefit for drugs granted US Food and Drug Administration …

JJ Skydel, AC Egilman, JD Wallach… - JAMA Health …, 2022 - jamanetwork.com
Importance Accelerated approval by the US Food and Drug Administration (FDA) grants
market authorization for drugs based on clinical trials using surrogate end points likely to …

Designing drug regimens that mitigate nonadherence

ED Counterman, SD Lawley - Bulletin of Mathematical Biology, 2022 - Springer
Medication adherence is a well-known problem for pharmaceutical treatment of chronic
diseases. Understanding how nonadherence affects treatment efficacy is made difficult by …

[HTML][HTML] Approvals and timing of new formulations of novel drugs approved by the US food and drug administration between 1995 and 2010 and followed through …

R Gupta, CJ Morten, AY Zhu… - JAMA Health …, 2022 - jamanetwork.com
Importance New formulations of prescription drugs can improve convenience and tolerability
for patients, but they also constitute manufacturer strategies to extend brand-name drug …

Nothing for Something: Marketing Cancer Drugs to Physicians Increases Prescribing Without Improving Mortality

C Carey, M Daly, J Li - 2024 - nber.org
Physicians commonly receive marketing-related transfers from drug firms. We examine the
impact of these relationships on the prescribing of physician-administered cancer drugs in …

Out-of-pocket costs of oral anticancer drugs for Medicare beneficiaries vary by strength and formulation

A Gupta, N Arora, W Haque, SMQ Hussaini… - Journal of Geriatric …, 2023 - Elsevier
2. Methods We included the 20 oral anticancer drugs with the highest spending in Medicare
Part D in 2020, used by 323,478 beneficiaries [4]. For each drug, we identified formulations …

The Economic Burden of Extended—Release Pharmaceuticals in Minnesota

J Zhou, A Everhart, L Smith, Y Qiu, Y Zhu - Public Health Review, 2020 - pubs.lib.umn.edu
Many drugs come in two forms, immediate—release and extended—release, that are
differentiated by the way the drug is released. Immediate—released formulations of drugs …

Switch from ER to IR formulations reduces Medicare/Medicaid spending

A Sumarsono - PharmacoEconomics & Outcomes News, 2020 - Springer
Switching from extended-release (ER) to immediate-release (IR) formulations for therapeutic
equivalent drugs may offer the potential to reduce Medicaid and Medicare spending in the …